VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
9 hedge funds and large institutions have $46.1M invested in Verona Pharma in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$8.64M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$8.21M |
| 3 |
O
OrbiMed
New York
|
+$7.77M |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$7.77M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$7.15M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NHAS
1
Novo Holdings A/S
Hellerup,
Denmark
| $8.64M | +$8.64M | +740,740 | New |
|
|
VC
2
Vivo Capital
Palo Alto,
California
| $8.21M | +$8.21M | +704,225 | New |
|
|
O
3
OrbiMed
New York
| $7.77M | +$7.77M | +666,666 | New |
|
|
NMC
4
NEA Management Company
Timonium,
Maryland
| $7.77M | +$7.77M | +666,666 | New |
|
|
FCMI
5
Foresite Capital Management III
Larkspur,
California
| $7.15M | +$7.15M | +613,601 | New |
|
|
TCM
6
Tekla Capital Management
Boston,
Massachusetts
| $3.21M | +$3.21M | +275,000 | New |
|
|
PA
7
Perceptive Advisors
New York
| $2.33M | +$2.33M | +200,000 | New |
|
8
Fidelity International
Hamilton,
Bermuda
| $873K | +$873K | +75,813 | New |
|
9
Jane Street
New York
| $133K | +$133K | +11,444 | New |
|